Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $0.90 in the prior trading day, ReShape Lifesciences Inc (NASDAQ: RSLS) closed at $0.73, down -18.83%. In other words, the price has decreased by -$18.83 from its previous closing price. On the day, 1.67 million shares were traded.
Ratios:
Our goal is to gain a better understanding of RSLS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.05.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 31 ’24 when STANKOVICH THOMAS sold 48 shares for $0.25 per share. The transaction valued at 12 led to the insider holds 22,777 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 0.35.
Stock Price History:
Over the past 52 weeks, RSLS has reached a high of $29.00, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is -76.70%, while the 200-Day Moving Average is calculated to be -89.90%.
Shares Statistics:
A total of 3.31M shares are outstanding, with a floating share count of 2.71M. Insiders hold about 18.08% of the company’s shares, while institutions hold 1.01% stake in the company.
